Scientists sound alarm over DNA risks in AI-designed “universal” coronavirus vaccine
New DNA-based coronavirus vaccine developed by Cambridge and DIOSynVax uses AI to target broad coronavirus strains but faces criticism over unproven safety and regulatory transparency.
First human trial reported 121 adverse events among 39 participants, with 23 linked to the vaccine, raising concerns about its risk profile.
Critics warn of DNA contamination risks, citing past discoveries of harmful plasmid contaminants in existing vaccines and undisclosed sequences in the new trial.
Regulators are accused of failing to ensure safety, with the Sarbeco vaccine’s plasmid sequence remaining undisclosed and no pre-trial genotoxicity studies conducted.
Gates Foundation and CEPI funding the project amid accelerated timelines and experimental delivery methods, including needle-free jet injection, spark ethical alarms.
Read Full Article: https://www.naturalnews.com/2026-06-18-scientists-alarm-dna-risks-ai-universal-vaccine.html
